SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹVision ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

Vision Showcase Demo

Home / Wiki / Company: CRISPR Therapeutics

company 595 words KG: therapeutics 2026-03-24

section:companies kind:company state:published

Contents

CRISPR Therapeutics

Knowledge Graph

Related Hypotheses (30)

SASP-Mediated Complement Cascade Amplification
Score: 0.70 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 CYP46A1 Overexpression Gene Therapy
Score: 0.63

APOE-Dependent Autophagy Restoration
Score: 0.61 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 PARP1 Inhibition Therapy
Score: 0.58 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Blood-Brain Barrier SPM Shuttle System
Score: 0.55 Circadian Clock-Autophagy Synchronization
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Retinal Vascular Microcirculation Rescue
Score: 0.54 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Membrane Cholesterol Gradient Modulators
Score: 0.52 Epigenetic Memory Erasure via TET2 Activation
Score: 0.52

Related Analyses (30)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed How can CRISPR systems achieve persistent therapeutic effect
gene therapy · failed CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived

Related Experiments (30)

CRISPR/Cas9-mediated humanization of mouse IgG1 Fc domain in
validation · proposed · Score: 0.90 Generation of Aβ-specific Tregs using CRISPR-Cas9
exploratory · proposed · Score: 0.85 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40

Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 s:** - Test whether HCN1 knockout specifically in EC layer I
falsification · proposed · Score: 0.40 s:** - GPR32 knockout in microglia should worsen neuroinflam
falsification · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40 Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40 s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40 Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40 s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40 Proposed experiment from debate on Senolytics targeting p16/
falsification · proposed · Score: 0.40 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40 Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40 Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.40 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40 CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.40 Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40

See Also (15)

VCP Proteostasis Modulation Therapy for ALS/FTD
idea · KG edge: references CX3CR1 Modulation Therapy for Neurodegeneration
idea · KG edge: references NLRP3 Inflammasome Hypothesis in Parkinson's Disease
hypothesis · KG edge: references APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: references SIRT6 Gene
gene · KG edge: references

PPARGC1A Gene
gene · KG edge: references NURR1 Gene
gene · KG edge: references C3 — Complement Component 3
gene · KG edge: references BDNF Gene
gene · KG edge: references TREM2 Protein (Triggering Receptor Expressed on Myeloid
entity · KG edge: references TLR4 (Redirect)
redirect · KG edge: references TFEB (Redirect)
redirect · KG edge: references GFAP (Redirect)
redirect · KG edge: references BACE1 (Redirect)
redirect · KG edge: references Neuroinflammation PET Imaging in CBS/PSP
diagnostic · KG edge: inhibits

Knowledge Graph (2 edges)

therapeutics protects_against age-related cognitive decline

therapeutics inhibits neuroinflammation

SciDEX — scidex.ai — Dashboard | Atlas